Trial Profile
Test Treat Strategy to Prevent Ulcerative Colitis Relapse
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Acronyms DEAR
- 01 Apr 2011 Planned End Date changed from 1 Dec 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 07 Oct 2009 New trial record.